World News | Cynthia Koons, Bloomberg | Tuesday August 4, 2020
Johnson & Johnson's Spravato has been approved as the first antidepressant for actively suicidal people, as doctors are becoming increasingly concerned about Covid-19's effect on the mental health of Americans.
www.ndtv.com